Division of Facial Plastic & Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A.
Frank N. Netter MD School of Medicine, Quinnipiac University, North Haven, Connecticut, U.S.A.
Laryngoscope. 2021 Jan;131(1):59-66. doi: 10.1002/lary.28551. Epub 2020 Feb 11.
Evolving hair transplantation (HT) techniques have offered new possibilities for hair restoration. However, the role of HT in patients with frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) remains unclear. This study aims to evaluate the outcomes and temporal relationship of HT in this population.
A literature search of three databases was conducted. We reviewed 1) literature reporting outcomes of patients with LPP or FFA who received HT, and 2) studies reporting the development of LPP or FFA resulting from HT.
Thirteen articles included 42 patients that provided data for evaluation. Fifteen patients had previously been diagnosed with FFA or LPP, and the remaining 27 patients developed disease after undergoing HT. Seven patients with FFA and eight patients with LPP received HT, with a mean sustained disease remission of 2.69 years prior to HT. In total, two of seven (29%) patients with FFA and five of eight (75%) patients with LPP experienced positive HT results over a follow-up period of 8-72 months. Interestingly, 27 patients without evidence of previous disease developed FFA or LPP following HT after a median duration of 16 months.
HT for LPP and FFA is feasible but results may be less favorable compared to HT for other causes. Outcomes may be more favorable for LPP than FFA but this was not statistically significant and evidence is very limited. FFA and LPP can also develop following HT in patients without previous evidence of disease.
NA Laryngoscope, 131:59-66, 2021.
不断发展的毛发移植(HT)技术为毛发修复提供了新的可能性。然而,HT 在额部纤维性脱发(FFA)和瘢痕性类天疱疮(LPP)患者中的作用尚不清楚。本研究旨在评估该人群接受 HT 的结果和时间关系。
对三个数据库进行了文献检索。我们回顾了 1)报告 LPP 或 FFA 患者接受 HT 后结果的文献,以及 2)报告因 HT 导致 LPP 或 FFA 发展的研究。
13 篇文章纳入了 42 名提供评估数据的患者。15 名患者先前被诊断为 FFA 或 LPP,其余 27 名患者在接受 HT 后出现疾病。7 名 FFA 患者和 8 名 LPP 患者接受了 HT,在 HT 前平均持续疾病缓解 2.69 年。总的来说,7 名 FFA 患者中有 2 名(29%)和 8 名 LPP 患者中有 5 名(75%)在 8-72 个月的随访期间获得了阳性 HT 结果。有趣的是,27 名无先前疾病证据的患者在接受 HT 后 16 个月中位数的时间后发展为 FFA 或 LPP。
HT 治疗 LPP 和 FFA 是可行的,但与 HT 治疗其他原因相比,结果可能不太理想。LPP 的结果可能比 FFA 更有利,但这没有统计学意义,证据非常有限。在没有先前疾病证据的患者中,HT 后也可能会发生 FFA 和 LPP。
无。喉科学,131:59-66,2021。